Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
AIM OF THE STUDY In the era of pangenotypic treatment regimens against hepatitis C virus (HCV) infection, data from postmarketing observational studies are crucial to better understand the treatment patterns used in specific countries and treatment outcomes under real-life conditions. We...
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2021-01-01
|
| Schriftenreihe: | Swiss Medical Weekly |
| Schlagworte: | |
| Online Zugang: | https://www.smw.ch/index.php/smw/article/view/2940 |